Randomized Trialhigh evidence
Finerenone and Blood Pressure in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Randomized Clinical Trial.
JAMA cardiology·July 8, 2026·PMID 42418169
Why it mattersBlood pressure management is a key component of heart failure care, but the blood pressure effects of newer agents like finerenone in HFmrEF/HFpEF are not well characterized. This analysis provides insight into the hemodynamic effects of finerenone and their potential link to clinical benefit.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled